PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT(1A) agonist actions. I. Neurochemical effects

H. C. Akunne, K. T. Zoski, M. D. Davis, L. W. Cooke, L. T. Meltzer, S. Z. Whetzel, Y. H. Shih, D. J. Wustrow, L. D. Wise, R. G. MacKenzie, L. M. Georgic, T. G. Heffner, T. A. Pugsley

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The neurochemical effects of a novel dopamine (DA) D2-like and serotonin (5-HT) 5-HT(1A) agonist, PD 158771, are described. PD 158771 exhibited affinities for human D(2L), D3 and D4.2 receptors expressed in Chinese hamster ovary (CHO)-K1 cells with K(i) (nM) values of 5.2, 13.7 and 34.8 respectively. PD 158771 showed high affinity for cloned human 5-HT(1A) (K(i) =2.6 nM) and rat hippocampal 5-HT(1A) receptors (K(i) =3.5 nM). Weaker affinities were observed at alpha 1-adrenergic (K(i) =43 nM), histamine H1 (IC50 =30 nM), 5-HT(2A) (K(i) =24.5 nM) and sigma (σ) -1 binding sites (K(i) =24.5 nM). In measures of in vitro functional activity, PD 158771 stimulated [3H]thymidine uptake in CHO p-5 cells transfected with hD3 receptors with a maximal effect of 23% relative to quinpirole. In hD2L, the corresponding value was 60% with an EC50 of 29 nM, again indicating partial DA agonist action of PD 158771. In vivo, PD 158771 produced a dose-related decrease in DA synthesis in the striatum and mesolimbic regions of rat brain treated with gamma-butyrolactone (GBL), indicating a DA autoreceptor agonist action. In animals not treated with GBL, PD 158771 produced a dose-related decrease in DA synthesis and extracellular DA. A decrease in 5-HT synthesis in several brain areas was observed consistent with an agonist response. Further support for DA autoreceptor agonist action is that PD 158771 produced a partial inhibition of the firing of substantia nigra zona compacta DA neurons, an effect reversed by haloperidol. In conclusion, PD 158771 exhibited affinities for DA and 5-HT receptors, appears to possess DA and 5-HT agonist actions; and it could provide improved antipsychotic profile with minimal side effects. Copyright (C) 2000 Elsevier Science Ltd.

Original languageEnglish (US)
Pages (from-to)1197-1210
Number of pages14
JournalNeuropharmacology
Volume39
Issue number7
DOIs
StatePublished - Jun 2000
Externally publishedYes

Fingerprint

Serotonin Receptor Agonists
Antipsychotic Agents
Dopamine
Serotonin
Dopamine Agonists
4-Butyrolactone
Autoreceptors
Cricetulus
Ovary
Quinpirole
PD 158771
Dopamine Agents
Receptor, Serotonin, 5-HT1A
Serotonin Receptors
Dopaminergic Neurons
Herpes Zoster
Brain
Haloperidol
Adrenergic Agents
Thymidine

Keywords

  • Agonist
  • Antipsychotic
  • Autoreceptor
  • DA receptors
  • Haloperidol
  • Thymidine uptake

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Drug Discovery
  • Pharmacology

Cite this

Akunne, H. C., Zoski, K. T., Davis, M. D., Cooke, L. W., Meltzer, L. T., Whetzel, S. Z., ... Pugsley, T. A. (2000). PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT(1A) agonist actions. I. Neurochemical effects. Neuropharmacology, 39(7), 1197-1210. https://doi.org/10.1016/S0028-3908(99)00224-5

PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT(1A) agonist actions. I. Neurochemical effects. / Akunne, H. C.; Zoski, K. T.; Davis, M. D.; Cooke, L. W.; Meltzer, L. T.; Whetzel, S. Z.; Shih, Y. H.; Wustrow, D. J.; Wise, L. D.; MacKenzie, R. G.; Georgic, L. M.; Heffner, T. G.; Pugsley, T. A.

In: Neuropharmacology, Vol. 39, No. 7, 06.2000, p. 1197-1210.

Research output: Contribution to journalArticle

Akunne, HC, Zoski, KT, Davis, MD, Cooke, LW, Meltzer, LT, Whetzel, SZ, Shih, YH, Wustrow, DJ, Wise, LD, MacKenzie, RG, Georgic, LM, Heffner, TG & Pugsley, TA 2000, 'PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT(1A) agonist actions. I. Neurochemical effects', Neuropharmacology, vol. 39, no. 7, pp. 1197-1210. https://doi.org/10.1016/S0028-3908(99)00224-5
Akunne, H. C. ; Zoski, K. T. ; Davis, M. D. ; Cooke, L. W. ; Meltzer, L. T. ; Whetzel, S. Z. ; Shih, Y. H. ; Wustrow, D. J. ; Wise, L. D. ; MacKenzie, R. G. ; Georgic, L. M. ; Heffner, T. G. ; Pugsley, T. A. / PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT(1A) agonist actions. I. Neurochemical effects. In: Neuropharmacology. 2000 ; Vol. 39, No. 7. pp. 1197-1210.
@article{a85adc6f525f46ef9fae094c8dd235cc,
title = "PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT(1A) agonist actions. I. Neurochemical effects",
abstract = "The neurochemical effects of a novel dopamine (DA) D2-like and serotonin (5-HT) 5-HT(1A) agonist, PD 158771, are described. PD 158771 exhibited affinities for human D(2L), D3 and D4.2 receptors expressed in Chinese hamster ovary (CHO)-K1 cells with K(i) (nM) values of 5.2, 13.7 and 34.8 respectively. PD 158771 showed high affinity for cloned human 5-HT(1A) (K(i) =2.6 nM) and rat hippocampal 5-HT(1A) receptors (K(i) =3.5 nM). Weaker affinities were observed at alpha 1-adrenergic (K(i) =43 nM), histamine H1 (IC50 =30 nM), 5-HT(2A) (K(i) =24.5 nM) and sigma (σ) -1 binding sites (K(i) =24.5 nM). In measures of in vitro functional activity, PD 158771 stimulated [3H]thymidine uptake in CHO p-5 cells transfected with hD3 receptors with a maximal effect of 23{\%} relative to quinpirole. In hD2L, the corresponding value was 60{\%} with an EC50 of 29 nM, again indicating partial DA agonist action of PD 158771. In vivo, PD 158771 produced a dose-related decrease in DA synthesis in the striatum and mesolimbic regions of rat brain treated with gamma-butyrolactone (GBL), indicating a DA autoreceptor agonist action. In animals not treated with GBL, PD 158771 produced a dose-related decrease in DA synthesis and extracellular DA. A decrease in 5-HT synthesis in several brain areas was observed consistent with an agonist response. Further support for DA autoreceptor agonist action is that PD 158771 produced a partial inhibition of the firing of substantia nigra zona compacta DA neurons, an effect reversed by haloperidol. In conclusion, PD 158771 exhibited affinities for DA and 5-HT receptors, appears to possess DA and 5-HT agonist actions; and it could provide improved antipsychotic profile with minimal side effects. Copyright (C) 2000 Elsevier Science Ltd.",
keywords = "Agonist, Antipsychotic, Autoreceptor, DA receptors, Haloperidol, Thymidine uptake",
author = "Akunne, {H. C.} and Zoski, {K. T.} and Davis, {M. D.} and Cooke, {L. W.} and Meltzer, {L. T.} and Whetzel, {S. Z.} and Shih, {Y. H.} and Wustrow, {D. J.} and Wise, {L. D.} and MacKenzie, {R. G.} and Georgic, {L. M.} and Heffner, {T. G.} and Pugsley, {T. A.}",
year = "2000",
month = "6",
doi = "10.1016/S0028-3908(99)00224-5",
language = "English (US)",
volume = "39",
pages = "1197--1210",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",
number = "7",

}

TY - JOUR

T1 - PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT(1A) agonist actions. I. Neurochemical effects

AU - Akunne, H. C.

AU - Zoski, K. T.

AU - Davis, M. D.

AU - Cooke, L. W.

AU - Meltzer, L. T.

AU - Whetzel, S. Z.

AU - Shih, Y. H.

AU - Wustrow, D. J.

AU - Wise, L. D.

AU - MacKenzie, R. G.

AU - Georgic, L. M.

AU - Heffner, T. G.

AU - Pugsley, T. A.

PY - 2000/6

Y1 - 2000/6

N2 - The neurochemical effects of a novel dopamine (DA) D2-like and serotonin (5-HT) 5-HT(1A) agonist, PD 158771, are described. PD 158771 exhibited affinities for human D(2L), D3 and D4.2 receptors expressed in Chinese hamster ovary (CHO)-K1 cells with K(i) (nM) values of 5.2, 13.7 and 34.8 respectively. PD 158771 showed high affinity for cloned human 5-HT(1A) (K(i) =2.6 nM) and rat hippocampal 5-HT(1A) receptors (K(i) =3.5 nM). Weaker affinities were observed at alpha 1-adrenergic (K(i) =43 nM), histamine H1 (IC50 =30 nM), 5-HT(2A) (K(i) =24.5 nM) and sigma (σ) -1 binding sites (K(i) =24.5 nM). In measures of in vitro functional activity, PD 158771 stimulated [3H]thymidine uptake in CHO p-5 cells transfected with hD3 receptors with a maximal effect of 23% relative to quinpirole. In hD2L, the corresponding value was 60% with an EC50 of 29 nM, again indicating partial DA agonist action of PD 158771. In vivo, PD 158771 produced a dose-related decrease in DA synthesis in the striatum and mesolimbic regions of rat brain treated with gamma-butyrolactone (GBL), indicating a DA autoreceptor agonist action. In animals not treated with GBL, PD 158771 produced a dose-related decrease in DA synthesis and extracellular DA. A decrease in 5-HT synthesis in several brain areas was observed consistent with an agonist response. Further support for DA autoreceptor agonist action is that PD 158771 produced a partial inhibition of the firing of substantia nigra zona compacta DA neurons, an effect reversed by haloperidol. In conclusion, PD 158771 exhibited affinities for DA and 5-HT receptors, appears to possess DA and 5-HT agonist actions; and it could provide improved antipsychotic profile with minimal side effects. Copyright (C) 2000 Elsevier Science Ltd.

AB - The neurochemical effects of a novel dopamine (DA) D2-like and serotonin (5-HT) 5-HT(1A) agonist, PD 158771, are described. PD 158771 exhibited affinities for human D(2L), D3 and D4.2 receptors expressed in Chinese hamster ovary (CHO)-K1 cells with K(i) (nM) values of 5.2, 13.7 and 34.8 respectively. PD 158771 showed high affinity for cloned human 5-HT(1A) (K(i) =2.6 nM) and rat hippocampal 5-HT(1A) receptors (K(i) =3.5 nM). Weaker affinities were observed at alpha 1-adrenergic (K(i) =43 nM), histamine H1 (IC50 =30 nM), 5-HT(2A) (K(i) =24.5 nM) and sigma (σ) -1 binding sites (K(i) =24.5 nM). In measures of in vitro functional activity, PD 158771 stimulated [3H]thymidine uptake in CHO p-5 cells transfected with hD3 receptors with a maximal effect of 23% relative to quinpirole. In hD2L, the corresponding value was 60% with an EC50 of 29 nM, again indicating partial DA agonist action of PD 158771. In vivo, PD 158771 produced a dose-related decrease in DA synthesis in the striatum and mesolimbic regions of rat brain treated with gamma-butyrolactone (GBL), indicating a DA autoreceptor agonist action. In animals not treated with GBL, PD 158771 produced a dose-related decrease in DA synthesis and extracellular DA. A decrease in 5-HT synthesis in several brain areas was observed consistent with an agonist response. Further support for DA autoreceptor agonist action is that PD 158771 produced a partial inhibition of the firing of substantia nigra zona compacta DA neurons, an effect reversed by haloperidol. In conclusion, PD 158771 exhibited affinities for DA and 5-HT receptors, appears to possess DA and 5-HT agonist actions; and it could provide improved antipsychotic profile with minimal side effects. Copyright (C) 2000 Elsevier Science Ltd.

KW - Agonist

KW - Antipsychotic

KW - Autoreceptor

KW - DA receptors

KW - Haloperidol

KW - Thymidine uptake

UR - http://www.scopus.com/inward/record.url?scp=0034017898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034017898&partnerID=8YFLogxK

U2 - 10.1016/S0028-3908(99)00224-5

DO - 10.1016/S0028-3908(99)00224-5

M3 - Article

C2 - 10760362

AN - SCOPUS:0034017898

VL - 39

SP - 1197

EP - 1210

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 7

ER -